What This New Circumcision Study Really Shows: Anxiety Doesn’t Go Away

A study focused on automation reveals a striking emotional outcome.

MEDICAL LITERATURE

A randomized clinical trial conducted in five urology departments in Chongqing, China, and just published in the Journal of Medical Internet Research, offers one of the clearest windows yet into what men actually experience emotionally after voluntary male medical circumcision (VMMC). The findings are striking.

The study followed 388 males, aged 15 and over, for 30 days after being circumcised. The central question wasn’t how to improve recovery, but whether a 10-minute video and written guidance might reduce patient inquiries and lighten the burden on overstretched clinicians. Midway through the trial, the researchers also introduced a generative AI chatbot to further automate follow-up and offload staff workload.

Yet the study’s most consequential revelation isn’t about videos or AI at all—it’s about patient anxiety. As an ancillary finding, the data show that anxiety spikes sharply after circumcision and remains elevated even at day 30, when the study ends—an important pattern that, to my knowledge, has received no attention.

At its core, the study set out to solve what the authors saw as a communication and workload problem in response to patient confusion, repeated questions, and escalating distress among those recovering from circumcision. In other words, the video and chatbot intervention was conceived not to explore patients’ emotional experiences, but to manage the volume and intensity of those experiences through technological means.

The study enrolled young men (most were 22-30 years old) and deliberately screened out anyone showing significant preexisting anxiety. Participants entered the trial with GAD-7 scores just above two.

The GAD-7 is a standard clinical tool for measuring anxiety, scored from 0 to 21. Scores of 0–4 indicate minimal anxiety, 5–9 mild anxiety, 10–14 moderate anxiety, and 15–21 severe anxiety.

In this study, anyone scoring 10 or above—moderate anxiety—was excluded. This was a psychologically stable group by design. There was no confounding mental-health crisis here and whatever anxiety emerged would be tied directly to the procedure itself.

And emerge it did. Here’s what happened:

Two weeks after circumcision, anxiety spiked dramatically in both the group that received standard postoperative information and the group that saw the video and interacted with the AI chatbot.

GAD-7 scores rose sharply: the standard information group climbed from 2.12 at baseline to 9.95 at day 14, while the enhanced information group rose from 2.22 to 7.06.

The cause wasn’t mysterious: pain, swelling, hematoma, difficulty sleeping, fear of complications, and uncertainty about sexual function. The genital focus of the surgery amplified these fears, and the study itself acknowledges the content of these worries. As the authors report, some participants expressed long-term concerns “regarding fear about sexual function or erectile dysfunction,” “pain during intercourse,” “pulling sensation after erection,” or “discomfort at the frenulum.”

The Fears Men Reported

But rather than engaging these fears as meaningful expressions of distress, the authors repeatedly frame them in ways that minimize their emotional significance. They write that patients exhibited “exaggerated concerns” and “repeated inquiries” about genital symptoms. They describe this reaction as “making a mountain out of a molehill.”

The problem—in their framing—is not the vulnerability men felt about their bodies, sexual function, or healing, but the burden these worries placed on clinicians. Even the months-later sexual concerns are mentioned only briefly before being minimized: the authors conclude that the symptoms “were mostly short-term,” without exploring the psychological impact on the individuals experiencing them.

The study’s novel interventions to prepare patients for the recovery period did blunt the severity of the mid-course anxiety spike. Men who watched the video had lower anxiety at the peak. But the intervention didn’t eliminate the anxiety altogether, nor did it erase the longer emotional aftermath.

Day 30: Anxiety Remains Elevated

But perhaps the most important finding is what happened on day 30. By the end of the follow-up period, anxiety had subsided from its peak—but it didn’t return to baseline in either group. Participants still reported mild anxiety one month after circumcision: the standard information group averaged 5.46, and the enhanced technology group 5.34. Both numbers are well above their starting point of roughly two. The emotional disruption persisted.

And that leads to a crucial question the study cannot answer: what happened next? The trial stopped collecting data at the 30-day mark, leaving a gap in our understanding of how long this anxiety truly lasts.

We don’t know whether anxiety continued to fall, plateaued, or rose again as men resumed sexual activity, confronted changes in sensation, or faced complications that often surface only after healing. The researchers conducted a handful of informal phone check-ins in the months that followed, and some men did report ongoing issues such as “pain during intercourse” and “pulling sensation after erection,” but these were not systematically measured.

Without long-term data, we can’t determine whether the anxiety documented at day 30 represents a temporary situation or the beginning of a more persistent psychological response.

Circumcision is often framed as a quick, simple procedure with an uncomplicated recovery. But this data shows that, in the case of VMMC, anxiety is not a short-lived reaction; it has a measurable arc. It begins low, spikes sharply around two weeks post-op, and remains elevated for at least a month. Whether it resolves cleanly after that—or becomes something longer lasting—remains unknown.

Even in a young and mentally healthy population, VMMC carries an emotional cost that extends well beyond the operating room.